- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Amplification of HER2 is a marker for global genomic instability ; volume:8 ; number:1 ; day:14 ; month:10 ; year:2008 ; pages:1-9 ; date:12.2008
BMC cancer ; 8, Heft 1 (14.10.2008), 1-9, 12.2008
- Urheber
-
Ellsworth, Rachel E.
- Beteiligte Personen und Organisationen
-
Ellsworth, Darrell L.
Patney, Heather L.
Deyarmin, Brenda
Love, Brad
Hooke, Jeffrey A.
Shriver, Craig D.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-8-297
- URN
-
urn:nbn:de:1111-2016030349364
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ellsworth, Rachel E.
- Ellsworth, Darrell L.
- Patney, Heather L.
- Deyarmin, Brenda
- Love, Brad
- Hooke, Jeffrey A.
- Shriver, Craig D.
- SpringerLink (Online service)
Ähnliche Objekte (12)
RAS/RAF mutations and microsatellite instability status in primary colorectal cancers according to HER2 amplification
Is HER2 amplification predictable by digital immunohistochemistry?
Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients
HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry
Scattered genomic amplification in dedifferentiated liposarcoma
Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer
DNA repair, genomic instability and cancer
MicroRNAs, genomic instability and cancer
Modulational instability and wave amplification in finite water depth
Droplet digital PCR using HER2/EIF2C1 ratio for detection of HER2 amplification in breast cancer tissues
HER2 genomic amplification in circulating tumor DNA and estrogen receptor positivity predict primary resistance to trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer
Author Correction: Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer
RAS/RAF mutations and microsatellite instability status in primary colorectal cancers according to HER2 amplification
Is HER2 amplification predictable by digital immunohistochemistry?
Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients
HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry
Scattered genomic amplification in dedifferentiated liposarcoma
Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer
DNA repair, genomic instability and cancer
MicroRNAs, genomic instability and cancer
Modulational instability and wave amplification in finite water depth
Droplet digital PCR using HER2/EIF2C1 ratio for detection of HER2 amplification in breast cancer tissues
HER2 genomic amplification in circulating tumor DNA and estrogen receptor positivity predict primary resistance to trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer
Author Correction: Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer
RAS/RAF mutations and microsatellite instability status in primary colorectal cancers according to HER2 amplification
Is HER2 amplification predictable by digital immunohistochemistry?
Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients
HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry
Scattered genomic amplification in dedifferentiated liposarcoma
Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer
DNA repair, genomic instability and cancer
MicroRNAs, genomic instability and cancer
Modulational instability and wave amplification in finite water depth
Droplet digital PCR using HER2/EIF2C1 ratio for detection of HER2 amplification in breast cancer tissues
HER2 genomic amplification in circulating tumor DNA and estrogen receptor positivity predict primary resistance to trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer